Webinar Preview
Discover an informative webinar exploring innovative strategies to enhance obesity clinical trials and learn about practical approaches for maximizing patient retention and protecting endpoint integrity.
The global obesity epidemic continues to rise, presenting a serious public health challenge. Studies show that more than 1 billion people worldwide are classified as obese, with rates doubling among adults, and quadrupling among children and adolescents since 1990.1 The associated risks — such as cardiovascular diseases, diabetes and certain cancers — underscore the urgent need for effective intervention strategies.
Addressing obesity through the clinical trials of anti-obesity drugs requires innovative, patient-centered approaches. In this webinar, the speakers will provide insights improving obesity clinical trial outcomes, with a focus on strategies to maximize patient retention. Additionally, this webinar will highlight the importance of endpoint protection to ensure the integrity and reliability of the trial’s results.
Register for this webinar today to learn how maximizing patient retention and protecting endpoint integrity are making a significant impact on the success of obesity clinical trials.
Speakers
![Jennifer Brown, Medpace](https://i0.wp.com/xtalks.com/wp-content/uploads/2024/07/Brown-Jennifer_150.jpg?fit=150%2C150&ssl=1)
Jennifer Brown, Sr. Director, Clinical Trial Management, Medpace
Ms. Jennifer Brown has a strong clinical background with 22 years in clinical research, including her work in Clinical Operations at Medpace as a CTM and a Sr. Director. She has global project management experience of Phase I-IV trials in a variety of indications, including obesity, dyslipidemia and diabetes within more than 26 countries.
![Amanda Sylvester, Medpace](https://i0.wp.com/xtalks.com/wp-content/uploads/2024/07/Sylvester-Amanda_150.jpg?fit=150%2C150&ssl=1)
Amanda Sylvester, DNP, APRN, CPNP-BC, Advanced Clinical Practitioner, Medpace
Dr. Amanda Sylvester is a board-certified Pediatric Nurse Practitioner with more than 16 years of clinical experience. She practiced Pediatric Endocrinology at Cincinnati Children’s Hospital for over ten years managing the care of pediatric and young adult patients. Amanda completed her Doctor of Nursing practice at Xavier University in Cincinnati, Ohio, with a concentration in Population Health.
Her therapeutic expertise covers a wide range of metabolic disorders with a focus on diabetes and obesity. She has experience in Phase I-III clinical trials in multiple metabolic indications but has a passion for working with obesity trials.
![Prudence King, Medpace](https://i0.wp.com/xtalks.com/wp-content/uploads/2024/07/King-Prudence_150.jpg?fit=150%2C150&ssl=1)
Prudence King, MSN, APRN, AGPCNP-BC, Advanced Clinical Practitioner, Medpace
Ms. Prudence King is a board-certified Adult Gerontology Primary Care Nurse Practitioner providing support to the Medpace Clinical Operations and Medical Monitor teams focused on nephrology. Ms. King has over 28 years of clinical, renal, specialized experience as well as extensive experience in public health. She has experience in Phase I-III global clinical trials in a variety of indications, including renal diseases, Alzheimer’s disease and obesity.
Who Should Attend?
This webinar will appeal to VPs, Directors, Managers and Department Heads working within:
- Clinical affairs
- Clinical research
- Clinical pharmacology
- Clinical outsourcing
- Clinical operations
- Regulatory affairs
- Medical affairs
What You Will Learn
Attendees will learn about:
- The complex factors contributing to obesity
- Strategies for enhancing patient retention in obesity trials
- Considerations for endpoint protection through study team collaboration and site education
Xtalks Partner
Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account